Medical Technologies

U.S. Food and Drug Administration Strengthens Cybersecurity Frameworks for Medical Devices

The U.S. Food and Drug Administration (FDA) reviews its ongoing efforts to secure medical devices through new regulatory guidance and technical collaboration to ensure patient safety throughout the product lifecycle.

2026-11-04
2 min read
1 views
certi.news Editorial Team
U.S. Food and Drug Administration Strengthens Cybersecurity Frameworks for Medical Devices

As the cybersecurity team at the U.S. Food and Drug Administration (FDA) celebrates a decade since its establishment, the agency highlights its ongoing commitment to protecting medical devices from digital threats that could impact patient safety and device effectiveness. The agency defines medical device cybersecurity as the proactive process of preventing unauthorized access, modification, or misuse of information stored or transmitted to and from a medical device.

Evolution of Regulatory Guidance

On June 27, 2025, the FDA issued final guidance titled "Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions." This document replaces the 2023 guidance and adds a specific section (Section VII) addressing the agency's recommendations regarding Section 524B of the Federal Food, Drug, and Cosmetic Act (FD&C Act) concerning cyber devices. This move aims to integrate cybersecurity into device design from the earliest stages to ensure protection throughout the entire Total Product Life Cycle (TPLC).

Why This News Matters

The importance of these updates lies in the increasing reliance on network-connected medical devices, which makes them vulnerable to attacks that could lead to service disruptions or the leakage of sensitive data. By collaborating with technical entities such as MITRE, the FDA is working to develop standards like the Software Bill of Materials (SBOM) to ensure data consistency and facilitate risk management in legacy devices that may lack modern security updates.

Risk Management and Alerts

The agency continues to issue periodic security alerts when vulnerabilities are discovered in specific devices, such as patient monitors from Contec and Epsimed, or insulin pumps from Medtronic. The agency emphasizes that these alerts are intended to guide healthcare facilities in taking immediate preventive measures to reduce the risk of unauthorized access. The agency also encourages manufacturers and users to regularly review updated guidance documents to ensure compliance with the latest digital security standards.

News source
FDA CDRH - Medical Device Technology
Open original source ↗
c
Author

certi.news Editorial Team

In the same category

You may also like

View all news